Articles by Jill E. Sackman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill E. Sackman

Germany Post AMNOG: Insights for BioPharma

The authors take a look at some of the recent developments in the German pharmaceutical market.
Nov 2, 2014

The authors take a look at some of the recent developments in the German pharmaceutical market.

Biotechnology Innovation and Growth in Israel

Israels diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and market growth.
Dec 2, 2013

Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and market growth.

Report from: Middle East and North Africa

The pharmaceutical industry grows despite conflict in the Middle East.
Oct 2, 2013

The pharmaceutical industry grows despite conflict in the Middle East.

Report from South Korea

The bio-pharmaceutical business outlook in South Korea remains positive.
Aug 2, 2013

The bio-pharmaceutical business outlook in South Korea remains positive.

Report from Southeast Asia

A unique demographic and payer mix make ASEAN an increasingly attractive region.
Jun 2, 2013

A unique demographic and payer mix make ASEAN an increasingly attractive region.

Report from Latin America

Latin America's diverse growing market seeks regulatory harmonization.
Apr 2, 2013

Latin America's diverse growing market seeks regulatory harmonization.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here